Cargando…

Effects of long-term macrolide therapy at low doses in stable COPD

Background: Chronic obstructive pulmonary disease (COPD) is currently the fourth largest fatal disease in the world, and is expected to rise to third place by 2020. Frequent acute exacerbations lead to increased mortality. Some suggestions for prophylactic use of macrolides in preventing COPD exacer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yueqin, Xuan, Shurui, Wu, Yunhui, Yao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572718/
https://www.ncbi.nlm.nih.gov/pubmed/31354258
http://dx.doi.org/10.2147/COPD.S205075

Ejemplares similares